These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26415233)

  • 1. Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
    Farina AR; Cappabianca L; Ruggeri P; Gneo L; Maccarone R; Mackay AR
    Oncotarget; 2015 Nov; 6(34):35636-51. PubMed ID: 26415233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
    Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
    Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
    Farina AR; Cappabianca L; Ruggeri P; Gneo L; Pellegrini C; Fargnoli MC; Mackay AR
    J Exp Clin Cancer Res; 2018 Jun; 37(1):119. PubMed ID: 29914559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.
    Farina AR; Tacconelli A; Cappabianca L; Cea G; Panella S; Chioda A; Romanelli A; Pedone C; Gulino A; Mackay AR
    Mol Cell Biol; 2009 Sep; 29(17):4812-30. PubMed ID: 19564412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
    Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
    Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.
    Farina AR; Di Ianni N; Cappabianca L; Ruggeri P; Ragone M; Ianni G; Gulino A; Mackay AR
    Biomed Res Int; 2013; 2013():740187. PubMed ID: 23841091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
    Tacconelli A; Farina AR; Cappabianca L; Desantis G; Tessitore A; Vetuschi A; Sferra R; Rucci N; Argenti B; Screpanti I; Gulino A; Mackay AR
    Cancer Cell; 2004 Oct; 6(4):347-60. PubMed ID: 15488758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
    Cappabianca L; Ruggieri M; Sebastiano M; Sbaffone M; Martelli I; Ruggeri P; Di Padova M; Farina AR; Mackay AR
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
    Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
    Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
    Cappabianca L; Zelli V; Pellegrini C; Sebastiano M; Maccarone R; Clementi M; Chiominto A; Ruggeri P; Cardelli L; Ruggieri M; Sbaffone M; Fargnoli MC; Guadagni S; Farina AR; Mackay AR
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.
    Ruggeri P; Farina AR; Di Ianni N; Cappabianca L; Ragone M; Ianni G; Gulino A; Mackay AR
    PLoS One; 2014; 9(4):e94568. PubMed ID: 24736663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells.
    Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation.
    Farina AR; Cappabianca L; Gneo L; Ruggeri P; Mackay AR
    Oncotarget; 2018 Feb; 9(9):8368-8390. PubMed ID: 29492201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TrkAIII expression in the thymus.
    Tacconelli A; Farina AR; Cappabianca L; Cea G; Panella S; Chioda A; Gallo R; Cinque B; Sferra R; Vetuschi A; Campese AF; Screpanti I; Gulino A; Mackay AR
    J Neuroimmunol; 2007 Feb; 183(1-2):151-61. PubMed ID: 17241672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importance.
    Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
    Cell Cycle; 2005 Jan; 4(1):8-9. PubMed ID: 15611661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment.
    Culvenor JG; Maher F; Evin G; Malchiodi-Albedi F; Cappai R; Underwood JR; Davis JB; Karran EH; Roberts GW; Beyreuther K; Masters CL
    J Neurosci Res; 1997 Sep; 49(6):719-31. PubMed ID: 9335259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phenylalanine-based folding determinant in intestinal sucrase-isomaltase that functions in the context of a quality control mechanism beyond the endoplasmic reticulum.
    Pröpsting MJ; Kanapin H; Jacob R; Naim HY
    J Cell Sci; 2005 Jun; 118(Pt 12):2775-84. PubMed ID: 15944403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic recycling of ERGIC53 between the endoplasmic reticulum and the Golgi complex is disrupted by nordihydroguaiaretic acid.
    Fujiwara T; Misumi Y; Ikehara Y
    Biochem Biophys Res Commun; 1998 Dec; 253(3):869-76. PubMed ID: 9918822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains.
    Nagaya H; Wada I; Jia YJ; Kanoh H
    Mol Biol Cell; 2002 Jan; 13(1):302-16. PubMed ID: 11809841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rab2A is a pivotal switch protein that promotes either secretion or ER-associated degradation of (pro)insulin in insulin-secreting cells.
    Sugawara T; Kano F; Murata M
    Sci Rep; 2014 Nov; 4():6952. PubMed ID: 25377857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.